Adenosine inhibits rat vascular smooth muscle cell (SMC) growth. Howev
er, the effects of adenosine on human vascular SMC proliferation and s
ynthesis of extracellular matrix proteins, such as collagen, are unkno
wn. The objective of this study was to characterize the effects of exo
genous and endogenous (SMC-derived) adenosine on human aortic SMC prol
iferation and collagen synthesis. Growth-arrested SMCs were stimulated
with 2.5% fetal calf serum (FCS) in the presence and absence of adeno
sine, 2-chloroadenosine (stable adenosine analogue), and with agents t
hat increase endogenous adenosine levels, including erythro-9-(2-hydro
xy-3-nonyl) adenine (EHNA), dipyridamole, and iodotubericidin. All of
these agents inhibited in a concentration-dependent manner FCS-induced
SMC proliferation as assessed by DNA synthesis (H-3-thymidine incorpo
ration) and cell counting, as well as collagen synthesis (H-3-proline
incorporation). EHNA, dipyridamole, and iodotubericidin increased extr
acellular levels of adenosine by 1.7-fold to 18-fold when added separa
tely to SMCs, and EHNA+iodotubericidin and EHNA+iodotubericidin+dipyri
damole increased extracellular adenosine levels by more than 392-fold.
Both KF17837 (selective A(2) antagonist) and DPSPX (A(1)/A(2) antagon
ist), but not DPCPX (selective A(1) antagonist), blocked the antimitog
enic effects of 2-chloroadenosine, EHNA, and dipyridamole on DNA and c
ollagen synthesis, suggesting the involvement of A(2A) and/or A(2B), b
ut excluding the participation of A(1), receptors. The lack of effect
of CGS21680 (selective A(2A) agonist), excluded involvement of A(2A) r
eceptors and suggested a major role for A(2B) receptors. A comparison
of the inhibitory potencies of 2-chloroadenosine, N-6-cyclopentyladeno
sine (selective A(1) agonist), NECA (A(1)/A(2) agonist), and MECA (A(1
)/A(2) agonist) were consistent with an A(2B) receptor subtype mediati
ng the inhibitory effects of adenosine on human aortic SMC proliferati
on. In conclusion, human aortic SMCs synthesize adenosine, and exogeno
us as well as endogenous (SMC-derived) adenosine inhibits SMC prolifer
ation and collagen synthesis via activation of A(2B) receptors.